Reyhanli, A.; Ortega-Márquez, J.; Pastora-Sesin, C.; Perin, J.P.; Gianlorenço, A.C.; Camargo, L.; Fregni, F.
Reconsidering Placebo Effects in Neuromodulation for Parkinson’s Disease: Lessons for Clinical Trials and Therapeutic Translation. Biomedicines 2026, 14, 532.
https://doi.org/10.3390/biomedicines14030532
AMA Style
Reyhanli A, Ortega-Márquez J, Pastora-Sesin C, Perin JP, Gianlorenço AC, Camargo L, Fregni F.
Reconsidering Placebo Effects in Neuromodulation for Parkinson’s Disease: Lessons for Clinical Trials and Therapeutic Translation. Biomedicines. 2026; 14(3):532.
https://doi.org/10.3390/biomedicines14030532
Chicago/Turabian Style
Reyhanli, Aybike, Jorge Ortega-Márquez, Carla Pastora-Sesin, Joao Pedro Perin, Anna Carolyna Gianlorenço, Lucas Camargo, and Felipe Fregni.
2026. "Reconsidering Placebo Effects in Neuromodulation for Parkinson’s Disease: Lessons for Clinical Trials and Therapeutic Translation" Biomedicines 14, no. 3: 532.
https://doi.org/10.3390/biomedicines14030532
APA Style
Reyhanli, A., Ortega-Márquez, J., Pastora-Sesin, C., Perin, J. P., Gianlorenço, A. C., Camargo, L., & Fregni, F.
(2026). Reconsidering Placebo Effects in Neuromodulation for Parkinson’s Disease: Lessons for Clinical Trials and Therapeutic Translation. Biomedicines, 14(3), 532.
https://doi.org/10.3390/biomedicines14030532